Accepted at 8:45 p.m. Dec, 15, 2024 by Jwill
Author: helen.nguyen
Co-authors: Jwill
Related Note: 1509215916515 1
Rationale for change

Consider adding clarification from UWorld qid:1892 (Answer Choice C)

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#AMBOSS::hw0ciR #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::12_Antimetabolites::*Nucleoside_Analogs::Gemcitabine !AK_UpdateTags::AnKing_Image::Ian::Cell_Cycle_Targets !AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::06_Cytarabine #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::03_Cytotoxic_Nucleoside_Analogs !AK_UpdateTags::AnKing_Image::!Subjects::Hematology::Cell_Cycle_Chemo_Targets #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::08_Cancer_therapy-cell_cycle #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#OME_banner #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::10_Cell_Cycle_Dependent_Drug_Targets